NewsBlockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs
The experimental weight-loss drug is a triple agonist and the first of its kind to reach a phase 3 clinical trial
More in Science
- ‘Godzilla’ of weight-loss drugs could provide other important health benefits The Guardian — Science
- NASA Opens 2027 Human Lander Challenge for Lunar Communications NASA
- Historic science museum in Philadelphia to close NPR — Science
- MRI Scans Might Reveal Signs of Alzheimer's Disease Seven Years Before a Telltale Marker Appears in the Brain Smithsonian Magazine
- This Virus Stole a Human Gene and Won’t Let Go of It The New York Times — Science